Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis.

Kemna E, Jentink W, te Molder I, Straalman I.

Clin Chem Lab Med. 2016 Mar;54(3):e89-92. doi: 10.1515/cclm-2015-0534. No abstract available.

PMID:
26351945
2.

Glycation rate of haemoglobins S, C, D, E, J and G, and analytical interference on the measurement of HbA1c with affinity chromatography and capillary electrophoresis.

Weykamp C, Kemna E, Leppink S, Siebelder C.

Clin Chem Lab Med. 2015 Aug;53(9):e207-10. doi: 10.1515/cclm-2014-1134. No abstract available.

PMID:
25719326
3.

HbA1c: performance of the Sebia Capillarys 2 Flex Piercing.

Weykamp C, Waenink-Wieggers H, Kemna E, Siebelder C.

Clin Chem Lab Med. 2013 Jun;51(6):e129-31. doi: 10.1515/cclm-2012-0560. No abstract available.

PMID:
23241674
4.

Effects of hemoglobin D and E on the measurement of HbA1c with the modified Menarini/ARKRAY ADAMS A1c HA-8180V analyser.

Weykamp C, Visser-Dekkers W, Kemna E, Siebelder C.

Clin Chim Acta. 2012 Dec 24;414:44-5. doi: 10.1016/j.cca.2012.07.023. No abstract available.

PMID:
23010358
5.

Mass spectrometry analysis of hepcidin peptides in experimental mouse models.

Tjalsma H, Laarakkers CM, van Swelm RP, Theurl M, Theurl I, Kemna EH, van der Burgt YE, Venselaar H, Dutilh BE, Russel FG, Weiss G, Masereeuw R, Fleming RE, Swinkels DW.

PLoS One. 2011 Mar 8;6(3):e16762. doi: 10.1371/journal.pone.0016762.

6.

Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.

Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW.

Haematologica. 2009 Dec;94(12):1748-52. doi: 10.3324/haematol.2009.010322.

7.

Regulation of serum hepcidin levels in sickle cell disease.

Kroot JJ, Laarakkers CM, Kemna EH, Biemond BJ, Swinkels DW.

Haematologica. 2009 Jun;94(6):885-7. doi: 10.3324/haematol.2008.003152. No abstract available. Erratum in: Haematologica. 2009 Aug;94(8):1184.

8.

(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies.

Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, Swinkels DW.

Anal Biochem. 2009 Jun 15;389(2):124-9. doi: 10.1016/j.ab.2009.03.039.

PMID:
19341701
9.

An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study.

Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP.

PLoS One. 2008;3(12):e4030. doi: 10.1371/journal.pone.0004030.

10.

Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection.

de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, Laarakkers CM, Silalye S, Verhoef H, Sauerwein RW, Swinkels DW, van der Ven AJ.

J Infect Dis. 2009 Jan 15;199(2):253-62. doi: 10.1086/595790.

11.

Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways.

Kartikasari AE, Roelofs R, Schaeps RM, Kemna EH, Peters WH, Swinkels DW, Tjalsma H.

Biochim Biophys Acta. 2008 Dec;1784(12):2029-37. doi: 10.1016/j.bbapap.2008.08.004.

PMID:
18775801
12.

Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency.

Kartikasari AE, Wagener FA, Yachie A, Wiegerinck ET, Kemna EH, Swinkels DW.

J Cell Mol Med. 2009 Sep;13(9B):3091-102. doi: 10.1111/j.1582-4934.2008.00494.x. Erratum in: J Cell Mol Med. 2010 Jun;14(6B):1874. Winkels, Dorine W [corrected to Swinkels, Dorine W].

13.

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.

Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, Tjalsma H.

PLoS One. 2008 Jul 16;3(7):e2706. doi: 10.1371/journal.pone.0002706.

14.

Hepcidin: from discovery to differential diagnosis.

Kemna EH, Tjalsma H, Willems HL, Swinkels DW.

Haematologica. 2008 Jan;93(1):90-7. doi: 10.3324/haematol.11705. Review.

15.

Regulation of hepcidin: insights from biochemical analyses on human serum samples.

Kemna EH, Kartikasari AE, van Tits LJ, Pickkers P, Tjalsma H, Swinkels DW.

Blood Cells Mol Dis. 2008 May-Jun;40(3):339-46.

PMID:
18023212
16.

Nitric oxide does not contribute to inflammation-induced hypoferremia in humans.

Kemna EH, Pickkers P, Tjalsma H, Swinkels DW.

Acta Haematol. 2007;118(3):149-52. No abstract available.

PMID:
17878712
17.

Effect of the new HJV-L165X mutation on penetrance of HFE.

van Dijk BA, Kemna EH, Tjalsma H, Klaver SM, Wiegerinck ET, Goossens JP, Slee PH, Breuning MH, Swinkels DW.

Blood. 2007 Jun 15;109(12):5525-6. No abstract available.

18.
19.

Novel urine hepcidin assay by mass spectrometry.

Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D.

Blood. 2005 Nov 1;106(9):3268-70.

20.

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.

Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D.

Blood. 2005 Sep 1;106(5):1864-6.

Items per page

Supplemental Content

Loading ...
Support Center